Literature DB >> 7249490

Steady-state kinetics and dosage requirements of cimetidine in renal failure.

R Larsson, B Norlander, G Bodemar, A Walan.   

Abstract

25 patients with different degrees of chronic stable renal failure received oral treatment with cimetidine over 6 days and a final dose in the morning of day 7. The doses of cimetidine were reduced according to the degree of renal failure. Plasma concentrations of cimetidine were determined before the morning dose on days 2,3,6 and before the final morning dose and during the day on day 7. 24-hour excretions of cimetidine were measured during the study and on day 7, 6 to 9 hours after the final morning dose. There were significant linear relationships between the values of creatinine clearance and plasma elimination rate constant of cimetidine (p less than 0.0025) and between the values of creatinine clearance and renal clearance of cimetidine (p less than 0.05). On the basis of the morning plasma concentrations before and the plasma concentration curve after the final morning dose on day 7 the following dose recommendations according to pretrial values of creatinine clearance are recommended for cimetidine treatment in renal failure: 5 to 15ml/min 200mg 2 or 3 times daily, 15 to 30ml/min 200mg 3 times daily and 30 to 75ml/min 200mg 4 times daily.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249490     DOI: 10.2165/00003088-198106040-00006

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  18 in total

1.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

Review 2.  Use of serum creatinine concentrations to determine renal function.

Authors:  T D Bjornsson
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

3.  Oral absorption of cimetidine and its clearance in patients with renal failure.

Authors:  R Larsson; G Bodemar; B Norlander
Journal:  Eur J Clin Pharmacol       Date:  1979-04-17       Impact factor: 2.953

4.  Rapid evaluation of creatinine clearance.

Authors:  J Kampmann; K Siersbaek-Nielsen; M Kristensen; J M Hansen
Journal:  Acta Med Scand       Date:  1974-12

5.  Functional defects in the aging kidney.

Authors:  S A Friedman; A E Raizner; H Rosen; N A Solomon; W Sy
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

6.  Bioavailability of cimetidine in man.

Authors:  S S Walkenstein; J W Dubb; W C Randolph; W J Westlake; R M Stote; A P Intoccia
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

7.  Cimetidine and mental-confusion.

Authors:  T J Robinson; T O Mulligan
Journal:  Lancet       Date:  1977-10-01       Impact factor: 79.321

8.  Cimetidine and renal failure.

Authors:  W Grave; J N Nadorp; J J Rutten
Journal:  Lancet       Date:  1977-10-01       Impact factor: 79.321

9.  Blood level of cimetidine in relation to age.

Authors:  A Redolfi; E Borgogelli; E Lodola
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

10.  Effects of renal failure on blood levels of cimetidine.

Authors:  K W Ma; D C Brown; D S Masler; S E Silvis
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

View more
  9 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 2.  Dosage regimen of cimetidine reviewed. Possible drug accumulation after multiple oral doses.

Authors:  J Prandota; I J Smith; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Pharmacokinetics of cimetidine after single doses and during continuous treatment.

Authors:  G Bodemar; B Norlander; A Walan
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

Review 4.  Pharmacokinetics and pharmacodynamics of H2-receptor antagonists in patients with renal insufficiency.

Authors:  U Gladziwa; U Klotz
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

6.  Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis.

Authors:  R Larsson; P Erlanson; G Bodemar; B Norlander; L Fransson; L Strouth
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 7.  Pharmacokinetic optimisation of the treatment of peptic ulcer in patients with renal failure.

Authors:  U Gladziwa; U Koltz
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

8.  Prediction of the renal clearance of cimetidine using endogenous N-1-methylnicotinamide.

Authors:  A Maiza; P T Daley-Yates
Journal:  J Pharmacokinet Biopharm       Date:  1991-04

9.  Physiologically-Based Pharmacokinetic Modelling of Creatinine-Drug Interactions in the Chronic Kidney Disease Population.

Authors:  Hiroyuki Takita; Daniel Scotcher; Rajkumar Chinnadurai; Philip A Kalra; Aleksandra Galetin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-11-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.